Cancer Science & Therapy

Internal Medicine Unit, Azienda Sanitaria Friuli Occidentale (AS FO), Via Savorgnano 2, San Vito al Tagliamento, PN 33078, Italy

Publications

• Case Reports   
  COVID-19 Hepatic Prodromal Syndrome in Patient with Non-Clear Cell Metastatic Renal Cell Carcinoma: A Case Report
  Author(s): Giovanni Lo Re*, Paolo Doretto, Massimiliano Balbi and Sandro Sulfaro
  
  Introduction: diagnostic and therapeutic difficulties for cancer are emerging in COVID-19 pandemic. In addition to interstitial pneumonia, disseminated intravascular coagulation and sepsis, liver injury (LI) is a fairly frequent occurrence, with significant weight on evolution and prognosis of COVID-19. Its involvement is linked to cholangiocytes ACE2. Excluded other pathogenesis, LI could represent prodromal phase of COVID-19, if initial diagnostic negativity will be followed by COVID-19 positivity. Clinical case: A 59-year-old male patient has diagnosis of metastatic papillary non-clear cell renal cell carcinoma (nccRCC). After neoadjuvant Sunitinib he was submitted to right nephrectomy with caval-atrial thrombectomy in extra-corporeal circulation. Thereafter he continues Sunitinib until disease progression (PD) to bone followed by Axitini.. Read More»
  DOI: 10.37421/1948-5956.2021.13.482

  Abstract HTML PDF